FI965140A - Tulehdussytokiinien inhibiitteinä hyödylliset hydroksialkyyliammoniumpyrimidiinit tai puriinit ja nukleosidijohdannaiset - Google Patents
Tulehdussytokiinien inhibiitteinä hyödylliset hydroksialkyyliammoniumpyrimidiinit tai puriinit ja nukleosidijohdannaiset Download PDFInfo
- Publication number
- FI965140A FI965140A FI965140A FI965140A FI965140A FI 965140 A FI965140 A FI 965140A FI 965140 A FI965140 A FI 965140A FI 965140 A FI965140 A FI 965140A FI 965140 A FI965140 A FI 965140A
- Authority
- FI
- Finland
- Prior art keywords
- hydroxyalkylammonium
- inhibitors
- inflammatory cytokines
- purines
- pyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/264,026 US5550132A (en) | 1994-06-22 | 1994-06-22 | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
PCT/US1995/007896 WO1995035304A1 (fr) | 1994-06-22 | 1995-06-21 | Derives hydroxyalkylammonium-pyrimidines ou purines et nucleosides utiles en tant qu'inhibiteurs de cytokines inflammatoires |
Publications (2)
Publication Number | Publication Date |
---|---|
FI965140A true FI965140A (fi) | 1996-12-20 |
FI965140A0 FI965140A0 (fi) | 1996-12-20 |
Family
ID=23004241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI965140A FI965140A0 (fi) | 1994-06-22 | 1996-12-20 | Tulehdussytokiinien inhibiitteinä hyödylliset hydroksialkyyliammoniumpyrimidiinit tai puriinit ja nukleosidijohdannaiset |
Country Status (11)
Country | Link |
---|---|
US (2) | US5550132A (fr) |
EP (1) | EP0766691B1 (fr) |
JP (1) | JPH10509416A (fr) |
AT (1) | ATE186545T1 (fr) |
AU (1) | AU2906795A (fr) |
CA (1) | CA2193645A1 (fr) |
DE (1) | DE69513285D1 (fr) |
FI (1) | FI965140A0 (fr) |
HU (1) | HUT76332A (fr) |
NO (1) | NO965520L (fr) |
WO (1) | WO1995035304A1 (fr) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739109A (en) * | 1988-12-16 | 1998-04-14 | Advanced Immunit Inc. | Method of treating neuroinflammatory degenerative diseases |
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
DE19516247A1 (de) * | 1995-05-03 | 1996-11-07 | Albrecht Prof Dr Wendel | Pyrogen-Untersuchungsverfahren |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
FR2746647B1 (fr) * | 1996-03-27 | 1998-05-15 | Oreal | Composition apaisante comprenant un extrait d'iridacee |
WO1997009056A1 (fr) * | 1995-09-07 | 1997-03-13 | L'oreal | Extrait d'iridacees et compositions le contenant |
GB9615202D0 (en) * | 1996-07-19 | 1996-09-04 | Smithkline Beecham Plc | Pharmaceuticals |
DK0948495T3 (da) | 1996-11-19 | 2004-06-01 | Amgen Inc | Aryl- og heteroarylsubstitueret, kondenseret pyrrol som antiinflammatoriske midler |
US6410729B1 (en) | 1996-12-05 | 2002-06-25 | Amgen Inc. | Substituted pyrimidine compounds and methods of use |
US6096753A (en) | 1996-12-05 | 2000-08-01 | Amgen Inc. | Substituted pyrimidinone and pyridone compounds and methods of use |
KR20010021905A (ko) * | 1997-07-15 | 2001-03-15 | 노미야마 아키히콰 | 신규인 푸린유도체 및 그 의약용도 |
US5998386A (en) * | 1997-09-19 | 1999-12-07 | Feldman; Arthur M. | Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue |
CN1158266C (zh) | 1998-10-01 | 2004-07-21 | 阿斯特拉曾尼卡有限公司 | 化合物 |
ES2219319T3 (es) | 1999-03-17 | 2004-12-01 | Astrazeneca Ab | Derivados de amida. |
GB9918035D0 (en) | 1999-07-30 | 1999-09-29 | Novartis Ag | Organic compounds |
US6280633B1 (en) | 1999-12-01 | 2001-08-28 | Fantom Technologies Inc. | Ozone sensor and method for use of same in water purification system |
EP1277747A4 (fr) * | 2000-03-28 | 2009-07-29 | Michio Ishibashi | Medicaments preventifs/remedes selectifs pour lesions evolutives apres endommagement d'un organe |
AU7931301A (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
NZ539735A (en) * | 2002-10-02 | 2009-07-31 | Dmi Biosciences Inc | Diagnosis and monitoring of diseases using markers, such as diketopiperazines |
CA3050734A1 (fr) | 2003-05-15 | 2004-12-02 | Ampio Pharmaceuticals, Inc. | Traitement de maladies a mediation des lymphocytes t |
US7745227B2 (en) * | 2003-08-12 | 2010-06-29 | Lawrence Livermore National Security, Llc | System for analysis of explosives |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
US20060086388A1 (en) * | 2004-10-27 | 2006-04-27 | Blake Fye | Venting device for degassing a flow of liquid in a closed system |
US8217047B2 (en) * | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
WO2012033792A2 (fr) | 2010-09-07 | 2012-03-15 | Dmi Acquisition Corp. | Traitement de maladies |
US8980834B2 (en) | 2011-10-10 | 2015-03-17 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
KR20140075772A (ko) | 2011-10-10 | 2014-06-19 | 앰피오 파마슈티컬스 인코퍼레이티드 | 면역 내성을 증가시킨 이식 의료 장비, 및 그의 제조 및 이식 방법 |
SG11201400283RA (en) | 2011-10-28 | 2014-03-28 | Ampio Pharmaceuticals Inc | Treatment of rhinitis |
MX2015010937A (es) | 2013-03-15 | 2015-10-29 | Ampio Pharmaceuticals Inc | Composiciones para la movilizacion, autodireccion, expansion y diferenciacion de celulas madre y metodos para usar las mismas. |
JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 関節病態の治療 |
WO2016209969A1 (fr) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
JPS60181075A (ja) * | 1984-02-28 | 1985-09-14 | Shoichiro Ozaki | ピリミジン類,その製法およびその利用法 |
DK163128C (da) * | 1986-08-12 | 1992-06-15 | Hoffmann La Roche | Pyrimidinnucleosider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende pyrimidinnucleosiderne og anvendelse af pyrimidinnucleosiderne |
GB8926611D0 (en) * | 1989-11-24 | 1990-01-17 | Xenova Ltd | Compound and its use |
US5130302A (en) * | 1989-12-20 | 1992-07-14 | Boron Bilogicals, Inc. | Boronated nucleoside, nucleotide and oligonucleotide compounds, compositions and methods for using same |
US5362732A (en) * | 1989-12-20 | 1994-11-08 | University Of North Carolina At Chapel Hill | Boronated compounds |
DE69223607T2 (de) * | 1991-04-05 | 1998-07-02 | Wisconsin Alumni Res Found | Verwendung von Substanzen zur Verhütung von Endotoxinschock |
US5306722A (en) * | 1992-09-02 | 1994-04-26 | Bristol-Myers Squibb Company | Thymidine derivatives and therapeutic method of use |
-
1994
- 1994-06-22 US US08/264,026 patent/US5550132A/en not_active Expired - Fee Related
-
1995
- 1995-06-07 US US08/476,704 patent/US5679684A/en not_active Expired - Fee Related
- 1995-06-21 DE DE69513285T patent/DE69513285D1/de not_active Expired - Lifetime
- 1995-06-21 HU HU9603535A patent/HUT76332A/hu unknown
- 1995-06-21 EP EP95924641A patent/EP0766691B1/fr not_active Expired - Lifetime
- 1995-06-21 CA CA002193645A patent/CA2193645A1/fr not_active Abandoned
- 1995-06-21 AU AU29067/95A patent/AU2906795A/en not_active Abandoned
- 1995-06-21 JP JP8502585A patent/JPH10509416A/ja active Pending
- 1995-06-21 WO PCT/US1995/007896 patent/WO1995035304A1/fr active IP Right Grant
- 1995-06-21 AT AT95924641T patent/ATE186545T1/de not_active IP Right Cessation
-
1996
- 1996-12-20 NO NO965520A patent/NO965520L/no unknown
- 1996-12-20 FI FI965140A patent/FI965140A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2193645A1 (fr) | 1995-12-28 |
HUT76332A (en) | 1997-08-28 |
US5679684A (en) | 1997-10-21 |
DE69513285D1 (de) | 1999-12-16 |
NO965520D0 (no) | 1996-12-20 |
WO1995035304A1 (fr) | 1995-12-28 |
AU2906795A (en) | 1996-01-15 |
US5550132A (en) | 1996-08-27 |
EP0766691A1 (fr) | 1997-04-09 |
HU9603535D0 (en) | 1997-02-28 |
EP0766691B1 (fr) | 1999-11-10 |
FI965140A0 (fi) | 1996-12-20 |
JPH10509416A (ja) | 1998-09-14 |
NO965520L (no) | 1997-02-21 |
ATE186545T1 (de) | 1999-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI965140A (fi) | Tulehdussytokiinien inhibiitteinä hyödylliset hydroksialkyyliammoniumpyrimidiinit tai puriinit ja nukleosidijohdannaiset | |
FI965141A (fi) | Tulehdussytokiinien inhibiitteinä hyödylliset N-substituoitu-(dihydroksiboryyli)alkyylipuriini-, indoli- ja pyrimidiinijohdannaiset | |
DK0590428T3 (da) | Azaquinoxaliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
EA199801047A1 (ru) | Замешенные призводные инлазола и их применение в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и фактора некроза опухоли (фно) | |
DK0801651T3 (da) | Hydroxymethyl-imidazodiazepiner og deres estere | |
DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
GR3026231T3 (en) | 3-aminopiperidine derivatives and related nitrogen containing heterocycles. | |
DK1501507T3 (da) | Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet | |
NO992337L (no) | Bicykliske arylkarboksamider og deres terapeutiske anvendelse | |
DK369482A (da) | 6alfa-methylprednisolonderivater, deres fremstilling og anvendelse | |
ES2087477T3 (es) | Derivados de pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica. | |
ES2081636T3 (es) | Preparacion de piperidinas sustituidas. | |
ES2194102T3 (es) | Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas. | |
DE59108770D1 (de) | Fluorverbindungen als Aromatase-Inhibitoren | |
DK0696278T3 (da) | Herbicidtvirkende substituerede 1-phenyl- eller 1-pyridinylbenzotriazoler | |
DK0579968T3 (da) | 4-Iminoquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse | |
EA200100065A1 (ru) | Производные гидроксамовой кислоты как ингибиторы продуцирования cd23 человека и высвобождения tnf | |
FI971177A (fi) | Bisyklisiä karboksiamideja 5-HT1A-antagonisteina | |
MXPA04004010A (es) | Acidos hidroxamicos de aril sulfonamida alenicos como inhibidores de tace y metaloproteinasa de matriz. | |
AU1002983A (en) | Substituted 1-benzoyl-2-phenyliminoimidazolines | |
ITMI921855A1 (it) | Derivati di catecolammine, processo per la loro preparazione e composizioni farmaceutiche che li contengono | |
BR9407232A (pt) | Compostos de tiocarbamoíla | |
IL72681A0 (en) | 4-alkylimidazole derivatives,their preparation and their use as nitrification inhibitors | |
CA2272138A1 (fr) | Composes de pyrazolopyrimidine et de pyrazolopyridine ayant une activite antagoniste crf | |
ATE37531T1 (de) | Bestimmte 2-(2-substituierte benzoyl)-1,3cyclohexandione. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |